East Brunswick, NJNCT05865535Now EnrollingIRB Ready

Cachexia Clinical Trial in East Brunswick, NJ

Access cutting-edge cachexia treatment through this clinical trial at a research site in East Brunswick. Study-provided care at no cost to qualified participants.

Sponsored by AVEO Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this East Brunswick location

Preparing your pre-screening questions…

Expert Care in East Brunswick

Access cachexia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cachexia treatment provided free

Apply for This East Brunswick Location

Check if you qualify for this cachexia clinical trial in East Brunswick, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to East Brunswick

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit East Brunswick site if eligible
  4. 4Begin participation

About This Cachexia Study in East Brunswick

This open label ascending dose study is designed to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of AV-380 in cancer patients with Cachexia. AV-380 is an immunoglobulin (Ig) G1 monoclonal antibody (mAb) intended to bind circulating human growth differentiation factor 15 (GDF-15), a cytokine involved in cancer-induced cachexia.

Sponsor: AVEO Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Patient must be ≥ 18 years of age at the time of signing the informed consent.
Patients with histologically confirmed solid tumor cancer who are actively receiving SoC therapy for this cancer.
Patients with cachexia as defined by Fearon criteria:
Weight loss \> 5% over past 6 months (in absence of simple starvation), or
BMI \< 20 kg/m2 and any degree of weight loss \> 2%, or
Sarcopenia and any degree of weight loss \> 2%
Patients with life expectancy ≥ 3 months

Exclusion Criteria

History of allergic or anaphylactic reaction to any monoclonal antibody (IgG protein) or molecules made of components of monoclonal antibody
Known brain metastases or cranial epidural disease unless adequately treated with radiotherapy and/or surgery (including radiosurgery) and stable for at least 2 weeks before first dose of study treatment.
Myocardial infarction or heart failure of New York Heart Association Grade 3-4 within 3 months prior to start of protocol therapy
Uncontrolled pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)
Cachexia is caused by other reasons (e.g., severe chronic obstructive pulmonary disease, heart failure, or HIV/AIDS), or the patient has uncontrolled reversible causes of reduced oral food intake, including, but not limited to, oral mucositis, nausea/vomiting, diarrhea, and/or obstruction, impairing the patient's ability to eat as determined by the Investigator.
Patients receiving tube feedings or parenteral nutrition at the time of Screening.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in East Brunswick?

Yes, this clinical trial (NCT05865535) has an active research site in East Brunswick, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cachexia Treatment Options in East Brunswick, NJ

If you're searching for cachexia treatment options in East Brunswick, NJ, this clinical trial (NCT05865535) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our East Brunswick research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cachexia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in East Brunswick?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · East Brunswick, NJ